Literature DB >> 7565091

Enhanced secretion through the Shigella flexneri Mxi-Spa translocon leads to assembly of extracellular proteins into macromolecular structures.

C Parsot1, R Ménard, P Gounon, P J Sansonetti.   

Abstract

Genes required for entry of Shigella flexneri into epithelial cells in vitro are clustered in two adjacent loci, one of which encodes secretory proteins, the IpaA-D proteins, and the other their dedicated secretion apparatus, the Mxi-Spa translocon. Ipa secretion, which is induced upon contact of bacteria with epithelial cells, is prevented during growth in vitro. Here, we show that ipaB and ipaD mutations lead to enhanced secretion of a set of about 15 proteins. These extracellular proteins and some Ipas associate in organized structures consisting of extended sheets. Growth of the wild-type strain in the presence of Congo red is shown to induce protein secretion through the Mxi-Spa translocon. Cultures grown to stationary phase in the presence of Congo red contain extracellular filaments whose composition and morphology are similar to those produced by the hypersecreting ipaB and ipaD mutants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565091     DOI: 10.1111/j.1365-2958.1995.tb02301.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  90 in total

1.  IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells.

Authors:  G Tran Van Nhieu; E Caron; A Hall; P J Sansonetti
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Spa33, a cell surface-associated subunit of the Mxi-Spa type III secretory pathway of Shigella flexneri, regulates Ipa protein traffic.

Authors:  R Schuch; A T Maurelli
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Snapshots of usher-mediated protein secretion and ordered pilus assembly.

Authors:  E T Saulino; E Bullitt; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors.

Authors:  K Tamano; S Aizawa; E Katayama; T Nonaka; S Imajoh-Ohmi; A Kuwae; S Nagai; C Sasakawa
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

5.  Shigella Spa32 is an essential secretory protein for functional type III secretion machinery and uniformity of its needle length.

Authors:  Koichi Tamano; Eisaku Katayama; Takahito Toyotome; Chihiro Sasakawa
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

6.  The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response.

Authors:  Takahito Sanada; Minsoo Kim; Hitomi Mimuro; Masato Suzuki; Michinaga Ogawa; Akiho Oyama; Hiroshi Ashida; Taira Kobayashi; Tomohiro Koyama; Shinya Nagai; Yuri Shibata; Jin Gohda; Jun-ichiro Inoue; Tsunehiro Mizushima; Chihiro Sasakawa
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

Review 7.  Type III secretion systems and bacterial flagella: insights into their function from structural similarities.

Authors:  Ariel Blocker; Kaoru Komoriya; Shin-Ichi Aizawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

Review 8.  Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.

Authors:  Daniela Büttner
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

9.  Bacterial macroscopic rope-like fibers with cytopathic and adhesive properties.

Authors:  Juan Xicohtencatl-Cortes; Zeus Saldaña; Wanyin Deng; Elsa Castañeda; Enrique Freer; Phil I Tarr; B Brett Finlay; José Luis Puente; Jorge A Girón
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

10.  Domains of the Shigella flexneri type III secretion system IpaB protein involved in secretion regulation.

Authors:  Da-Kang Shen; Saroj Saurya; Carolin Wagner; Hiroaki Nishioka; Ariel J Blocker
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.